Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 3 mins

Experience with continuous glucose monitoring in reducing diabetes management burden for older Chinese Americans with cognitive impairment

AI Summary
  • CGM is feasible and eases diabetes management burden for older Chinese Americans with cognitive impairment, improving food, portion and exercise decisions, confidence, and disease understanding.
  • CGM enhances care partner involvement and communication, motivates behavioural changes, and enables remote, anytime data review to support ongoing diabetes self-management.
  • Clinicians report CGM provides real-time, shareable continuous data that improves safety, supports individualised treatment decisions, and benefits from automatic data transmission models.
Summarise with AI (MRCPsych/FRANZCP)

Hum Factors Health. 2026 Dec;10:100156. doi: 10.1016/j.hfh.2026.100156. Epub 2026 Aug 11.

ABSTRACT

OBJECTIVE: We aimed to study the experience of using continuous glucose monitoring (CGM) among older Chinese Americans with cognitive impairment (CI) and their care partners. We also explored physicians’ perspectives on using CGM in older adults with cognitive decline.

BACKGROUND: CI can heighten the challenges of managing type 2 diabetes (T2D), particularly among older Chinese Americans due to the interplays of cultural, financial, and health-related burdens and older adults with cognitive decline that add additional challenges of diabetes management. The application of CGM in such populations remains understudied.

METHOD: Older Chinese American adults with CI and T2D and their care partners were recruited from the New York City (NYC) community. Clinicians who had clinical experience of the application of CGM in individuals with diabetes and cognitive decline were recruited nationally. After brief education, patients used CGM for 10 days and shared the data with their care partners. In-depth interviews were conducted among older Chinese Americans with both T2D and CI (n = 11), care partners (n = 11), and clinicians (n = 8), transcribed, and then thematically analyzed using ATLAS.ti software.

RESULTS: Older Chinese Americans with both T2D and CI had a mean age of 74.5 ± 5.2 years, and 63.6% were women. They reported CGM helped them assess the influence of various foods on glucose levels in order to choose appropriate foods (n = 10) and portion sizes (n = 5), gain insight on the role and impact of exercise (n = 5), enhance care partner involvement (n = 5) and communication (n = 4), and promote a positive mindset by improving management confidence or disease understanding (n = 9) in diabetes self-management. Care partners echoed similar sentiments but added that the device enhanced diabetes management as it was more persuasive in motivating behavioral changes (n = 5), and increased care partner involvement by allowing them to check in more often (n = 6) and review data with the patient at anytime and anywhere (n = 4). Clinicians emphasized that CGM provided real-time, shareable continuous data, in contrast with occasional A1C results (n = 5), improving safety, supporting individualized treatment decisions (n = 5), highlighting the importance of strong care partner support systems (n = 8), and noting that newer models with automatic data transmission (Dexcom G6/G7) are especially valuable (n = 5).

CONCLUSION: Our findings indicate that CGM was feasible in easing management burden for older Chinese Americans with CI and T2D, while also enhancing care partner involvement and supporting clinicians in individualized treatment decisions.

APPLICATION: Potential applications of this research include the adaptation of the CGM in older Chinese Americans with CI and T2D to better accommodate their cultural needs in diabetes management.

PMID:43032756 | PMC:PMC13763130 | DOI:10.1016/j.hfh.2026.100156

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD